Bora CDMO Bora CDMO

X

CAS 74163-81-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
L-Porretine
Also known as: 74163-81-8, L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, (3s)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, L-porretine, H-tic-oh, (s)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid
Molecular Formula
C10H11NO2
Molecular Weight
177.20  g/mol
InChI Key
BWKMGYQJPOAASG-VIFPVBQESA-N
FDA UNII
737G46U1NP

1 2D Structure

L-Porretine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
2.1.2 InChI
InChI=1S/C10H11NO2/c12-10(13)9-5-7-3-1-2-4-8(7)6-11-9/h1-4,9,11H,5-6H2,(H,12,13)/t9-/m0/s1
2.1.3 InChI Key
BWKMGYQJPOAASG-VIFPVBQESA-N
2.1.4 Canonical SMILES
C1C(NCC2=CC=CC=C21)C(=O)O
2.1.5 Isomeric SMILES
C1[C@H](NCC2=CC=CC=C21)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
737G46U1NP
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 74163-81-8

2. L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid

3. (3s)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid

4. L-porretine

5. H-tic-oh

6. (s)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid

7. (s)-(-)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid

8. (3s)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid

9. S-(-)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid

10. 3-isoquinolinecarboxylic Acid, 1,2,3,4-tetrahydro-, (3s)-

11. 737g46u1np

12. 1,2,3,4-tetrahydroisoquinoline-3(s)-carboxylic Acid

13. (-)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid

14. (s)-1,2,3,4-tetrahydro-3-isoquinoline-carboxylic Acid

15. 1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, (s)-

16. (s)-(-)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid

17. Mfcd00144533

18. L-tic

19. Unii-737g46u1np

20. H-l-tic-oh

21. (r)-(+)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid

22. Schembl288272

23. S-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid

24. Chembl447576

25. Act01929

26. Cs-d1187

27. Str03867

28. Zinc3881715

29. Akos016842273

30. Ts-02454

31. A9522

32. Am20060719

33. J1119

34. T1515

35. 163t818

36. J-650310

37. L-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid

38. Q-103215

39. 1,2,3,4-tetrahydro-3(s)-isoquinolinecarboxylic Acid

40. 1,2,3,4-tetrahydroisoquinoline-(3s)-carboxylic Acid

41. Q27266148

42. S-1,2,3,4-tetrahydro-3-isoquinoline Carboxylic Acid

43. (3s)-1,2,3,4-tetrahydro-3-isoquinolinecarbocylic Acid

44. (3s)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid

45. L-(3s)1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid

46. Quinapril Hydrochloride Impurity A [ep Impurity]

47. Z1696862396

48. (s)-(-)-1,2,3,4-tetrahydro-3-isoquindinecarboxylic Acid

49. (s)-(-)-1,2,3,4-tetrahydro-3-isoquinoline-carboxylic Acid

50. (s)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid, 97%

51. 1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, (-)-

52. 1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, (3s)-

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 177.20 g/mol
Molecular Formula C10H11NO2
XLogP3-1.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass177.078978594 g/mol
Monoisotopic Mass177.078978594 g/mol
Topological Polar Surface Area49.3 Ų
Heavy Atom Count13
Formal Charge0
Complexity205
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
77497-97-3
Quinapril
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Flag China
Digital Content Digital Content
URL Supplier Web Content
77497-97-3
Quinapril
LUNA Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients an...
LUNA Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients and intermediate chemicals for generic pharmaceutical companies. Our Development Team focus strategically on the core therapeutic areas: cardiovascular, anti-depressant, allergic, healthcare and plant extraction. We provide technical support and efficient regulatory documentation for manufacturers, intellectual property(IP) was always carefully considered as well. We also provide excellent outsourcing services to customers and laboratory support.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
77497-97-3
Quinapril
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY